In the news release, Haemonetics Sets Date for Publishing First
Quarter Fiscal Year 2024 Results: August 8,
2023, issued 10-Jul-2023 by
Haemonetics Corporation over PR Newswire, we are advised by the
company that in the third paragraph there was an incorrect link to
the webcast. The complete, corrected release follows:
Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2024
Results: August 8, 2023
BOSTON, July 10,
2023 /PRNewswire/ -- Haemonetics Corporation (NYSE:
HAE) announced that the Company intends to publish first quarter
fiscal year 2024 financial results at 6:00 am ET on Tuesday, August 8, 2023. The Company will hold a
conference call with investors and analysts to discuss results and
answer questions at 8:00 am ET on
August 8, 2023.
The call can be accessed via teleconference at: Q1 2024
Haemonetics Corporation Earnings Conference Call. Once registration
is completed, participants will receive a dial-in number along with
a personalized PIN to access the call. While not required, it is
recommended that participants join 10 minutes prior to the event
start.
A live webcast of the call can be accessed on Haemonetics'
investor relations website. Webcast
Link: https://edge.media-server.com/mmc/p/y8b7kg5q
A replay of the conference call and webcast will be available
for one year beginning on August 8,
2023 at 11:00 am ET using the
conference call webcast link provided in this press release.
ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company
dedicated to providing a suite of innovative medical products and
solutions for customers, to help them improve patient care and
reduce the cost of healthcare. Our technology addresses important
medical markets: blood and plasma component collection, the
surgical suite and hospital transfusion services. To learn more
about Haemonetics, visit www.haemonetics.com.
Investor
Contacts:
|
|
Olga Guyette, Sr.
Director-Investor Relations & Treasury
|
David Trenk,
Manager-Investor Relations
|
(781)
356-9763
|
(203)
733-4987
|
olga.guyette@haemonetics.com
|
david.trenk@haemonetics.com
|
|
|
Media
Contact:
|
|
Josh Gitelson,
Director-Global Communications
|
|
(781)
356-9776
|
|
josh.gitelson@haemonetics.com
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-first-quarter-fiscal-year-2024-results-august-8-2023-301873371.html
SOURCE Haemonetics Corporation